Impact of estrogen receptor levels on outcome in triple negative breast cancer patients treated with (neo)adjuvant chemotherapy

被引:0
|
作者
Griguolo, Gaia [1 ]
Dieci, Maria Vittoria [1 ]
Bottosso, Michele [1 ]
Tsvetkova, Vassilena [1 ]
Giorgi, Carlo Alberto [2 ]
Angelini, Silvia [2 ]
Tasca, Giulia [2 ]
Cumerlato, Enrico [1 ]
Lo Mele, Marcello [3 ]
Conte, PierFranco [1 ]
Guarneri, Valentina [1 ]
机构
[1] Univ Padua, Padua, Italy
[2] Ist Oncol Veneto IRCCS, Padua, Italy
[3] Azienda Osped Padova, Padua, Italy
关键词
D O I
10.1158/1538-7445.SABCS19-P3-08-05
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P3-08-05
引用
收藏
页数:3
相关论文
共 50 条
  • [41] Prognostic Impact of IGKC in Breast Cancer Patients Treated with Adjuvant Chemotherapy
    Heimes, Anne-Sophie
    Kraemer, Hannah
    Hasenburg, Annette
    Schmidt, Marcus
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 : 210 - 210
  • [42] Impact of neoadjuvant Chemotherapy Regimen on Outcome in Patients with triple negative Breast Cancer: Real World Data
    Hatzipanagiotou, M. E.
    Zeltner, V.
    Gerken, M.
    Pigerl, M. C.
    Raepple, S.
    Roth, J.
    Ortmann, O.
    Klinkhammer-Schalke, M.
    Seitz, S.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2024, 84 (06) : E35 - E35
  • [43] Changes in intestinal microbiota in postmenopausal oestrogen receptor-positive breast cancer patients treated with (neo)adjuvant chemotherapy
    Romy Aarnoutse
    Janine Ziemons
    Lars E. Hillege
    Judith de Vos-Geelen
    Maaike de Boer
    Saskia M. P. Bisschop
    Birgit E. P. J. Vriens
    Jeroen Vincent
    Agnes J. van de Wouw
    Giang N. Le
    Koen Venema
    Sander S. Rensen
    John Penders
    Marjolein L. Smidt
    npj Breast Cancer, 8
  • [44] Changes in intestinal microbiota in postmenopausal oestrogen receptor-positive breast cancer patients treated with (neo)adjuvant chemotherapy
    Aarnoutse, Romy
    Ziemons, Janine
    Hillege, Lars E.
    de Vos-Geelen, Judith
    de Boer, Maaike
    Bisschop, Saskia M. P.
    Vriens, Birgit E. P. J.
    Vincent, Jeroen
    van de Wouw, Agnes J.
    Le, Giang N.
    Venema, Koen
    Rensen, Sander S.
    Penders, John
    Smidt, Marjolein L.
    NPJ BREAST CANCER, 2022, 8 (01)
  • [45] Impact of Presenting Stage on Overall Survival in Patients Treated with Neoadjuvant Chemotherapy for Triple Negative Breast Cancer
    Carroll, Jennifer F.
    Hoskin, Tanya L.
    Leon-Ferre, Roberto A.
    Boughey, Judy C.
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (08) : 5132 - 5140
  • [46] The Impact of Presenting Stage on Overall Survival in Patients Treated with Neoadjuvant Chemotherapy in Triple Negative Breast Cancer
    Carroll, Jennifer F.
    Hoskin, Tanya L.
    Ferre, Roberto A. Leon
    Boughey, Judy C.
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (01) : S8 - S8
  • [47] The impact of body composition change on neo-adjuvant chemotherapy for breast cancer patients
    Iwase, T.
    Sangai, T.
    Ishigami, E.
    Sakakibara, J.
    Fujisaki, K.
    Shiina, N.
    Fujimoto, H.
    Sakakibara, M.
    Nagashima, T.
    Miyazaki, M.
    BREAST, 2015, 24 : S106 - S107
  • [48] Androgen receptor expression and outcome of neoadjuvant chemotherapy in triple-negative breast cancer
    Di Leone, A.
    Fragomeni, S. M.
    Scardina, L.
    Ionta, L.
    Mule, A.
    Magno, S.
    Terribile, D.
    Masetti, R.
    Franceschini, G.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2021, 25 (04) : 1910 - 1915
  • [49] Does Time to Adjuvant Chemotherapy Affect Outcomes in Patients with Triple Negative Breast Cancer?
    Pomponio, Maria
    Keele, Luke
    Tchou, Julia C.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2019, 229 (04) : E76 - E77
  • [50] Prognostic Factors in Triple Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy
    Wada, N.
    Yoneyama, K.
    Yamauchi, C.
    Fujii, S.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : S140 - S140